Citizens Maintains Market Outperform on MiMedx Group, Lowers Price Target to $7
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst David Turkaly maintains MiMedx Group (NASDAQ:MDXG) with a Market Outperform and lowers the price target from $10 to $7.
Citizens analyst David Turkaly maintains MiMedx Group (NASDAQ:MDXG) with a Market Outperform and lowers the price target from $10 to $7.